Arch Point Investors Pfizer Inc Transaction History

Arch Point Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $229,202 - $339,753	-5,547 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $217,719 - $279,679	5,547 New	5,547 $239,000
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $727,398 - $882,441	-24,150 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $135,825 - $194,065	5,025 Added 26.27%	24,150 $788,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $11,241 - $14,576	-346 Reduced 1.78%	19,125 $687,000
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $3,000 - $3,296	-80 Reduced 0.41%	19,471 $827,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $46,164 - $52,632	-1,200 Reduced 5.78%	19,551 $809,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $83,109 - $88,603	-2,520 Reduced 10.83%	20,751 $753,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $721,401 - $794,704	23,271	23,271 $830,000

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.